19 June 2013
Keywords: sheffield, starts, rbc-cd4, trials, medical, project, development
Article | 14 August 1995
US medical project development company Sheffield Medical Technologies
has started a Phase I/IIa clinical trial with RBC-CD4, a therapeutic
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
27 November 1995
29 January 1996
18 June 2013
© 2013 thepharmaletter.com